Participated · Seed · Sep 2025

Greenitio has developed a patented green-chemistry platform that produces high-performance biopolymers using mushroom-derived chitosan as the primary feedstock (50–99% of formulations). Its water-based, ambient-temperature process avoids toxic solvents and chemical waste, yields materials that are 100% bio‑based and naturally degradable, and reportedly cuts carbon footprint by 87% versus conventional chemistry. The startup offers cationic, tunable ingredients that act as drop-in replacements in water- and oil-based formulations, with claimed benefits including SPF boosting, film-forming, water resistance, anti-inflammatory effects, deep moisturisation and active delivery. Three flagship lines—Chitosola, Chitobela and Chitobe—are listed in the International Nomenclature of Cosmetic Ingredients and registered with China’s IECIC. Greenitio operates R&D, lab-scale and pilot production in Singapore and uses a toll manufacturer in India with capacity to scale toward 25 tonnes per month; it plans a Benelux subsidiary to support European commercialisation. The company targets cosmetics, personal care, home care and specialty chemicals customers and is developing bespoke derivatives with testing agreements in place with unnamed global beauty and ingredient partners.

Led · Equity · Mar 2025

Ocean Ledger develops proprietary geospatial models that detect anomalies in shoreline movement, underwater topography, and natural coastal defenses. Its core customers include engineering firms, municipalities, environmental services, and insurance companies seeking better forecasting and monitoring of climate-driven coastal threats. The company has collaborated with commercial satellite data provider Planet Labs PBC and is exploring partnerships with marine drone and sensor companies. Ocean Ledger is also working with insurers to develop new products, including long-term catastrophe bonds. Led by CEO Paige Roepers, the company plans to use new funding to scale adoption of its solutions. The article does not disclose revenue or other operating metrics.

Led · Seed · Nov 2023

Invasive Species Corporation (a Delaware Public Benefit Corp) develops, discovers and markets bio-based solutions to control invasive species across water, forestry and agriculture. Its current commercial product Zequanox® targets invasive zebra and quagga mussels, and it is developing Piscamycin™ for invasive carp; the company is also in the discovery phase on a microbial natural product (bioherbicide) for problematic weeds. ISC reports it is currently selling Zequanox® and advancing Piscamycin™ while pursuing additional product lines. The company recently received a $388,000 grant from the Washington State Department of Agriculture to find a microbial solution for burrowing shrimp that harm oyster beds. ISC says it will use new financing to improve and expand product lines and to continue developing stronger customer relationships. The firm positions its mission around regenerating ecological biodiversity and deploying natural, sustainable control solutions to address invasive-species-driven biodiversity loss and climate impacts.

Led · Equity · Feb 2022

Newcastle, New South Wales–based Hone develops handheld spectrometer hardware and machine‑learning software for in‑field measurement of soil carbon and other agrifood properties. The company began with moisture and protein measurement in grains and oilseeds and has expanded into liquid analysis for food processing; its Hone Carbon subsidiary focuses on soil carbon testing. Hone sells devices for a one‑off fee and a subscription for access to spectroscopy models and its software platform. The startup claims its spectroscopy approach produces results in the same format as conventional labs while being up to five times cheaper and delivering near‑real‑time readings. Hone Carbon’s products meet Australia’s Clean Energy Regulator requirements for ACCU generation and the business currently serves about 10 customers, including CSIRO, Loam Bio, AgriProve and Limagrain, and runs farm pilots. The company says it will use new backing to scale production from building and deploying tens of devices a year to hundreds and thousands, and to expand workshop and support infrastructure.